• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » ViroPharma expands in PA, creates 151 jobs

ViroPharma expands in PA, creates 151 jobs

September 11, 2012
CenterWatch Staff

ViroPharma, a biopharmaceutical company that focuses on rare diseases, will expand its operations in Exton, Penn., and create 151 new, high-paying jobs.

"ViroPharma is a true Pennsylvania success that continues to grow and create jobs in the region," said Tom Corbett, governor of Pennsylania. "What started as a small team of entrepreneurs in Exton has now evolved into an international biopharmaceutical company employing hundreds of Pennsylvanians."

ViroPharma will nearly double its current available space by leasing an additional 71,000 square feet of office space to accommodate planned growth. The expansion will enable the company to retain its existing 188 employees and create at least 151 new jobs within three years.

The company received a $583,000 funding offer from the Department of Community and Economic Development, including a $130,000 Pennsylvania First grant and $453,000 in Job Creation Tax Credits. 

"For us it is about growth. ViroPharma has been in Exton for many years and we love our home here," said Vincent J. Milano, president and CEO of ViroPharma. "We're committed to this area for the long-term and look forward to creating opportunities in this community."

    Upcoming Events

    • 16Oct

      MAGI@home Clinical Research Conference 2023

    • 25Oct

      2023 WCG Patient Forum

    • 26Oct

      FDA in 2024: What to Expect in an Election Year

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Donna Snyder

      New WCG Executive Physician Outlines Goals for Clinical Research

    • Hand Shake at Meeting

      Partnership to Bolster Trials in Low Resource Regions Kicks Off

    • Guidelines-360x240.png

      Major Industry Groups Offer Feedback on ICH’s E6(R3) Guidelines

    • AsktheExpertsBadge-360x240.png

      Ask the Experts: Monitoring

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing